126 related articles for article (PubMed ID: 37348842)
1. Oral Anticoagulant Therapy and Risk of Admission to Long-Term Care in patients With Atrial Fibrillation: A Nationwide Cohort Study.
Teppo K; Airaksinen KEJ; Halminen O; Linna M; Jaakkola J; Haukka J; Putaala J; Mustonen P; Langén VL; Kinnunen J; Hartikainen J; Lehto M
J Am Med Dir Assoc; 2023 Oct; 24(10):1484-1489. PubMed ID: 37348842
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation.
Teppo K; Airaksinen KEJ; Jaakkola J; Halminen O; Salmela B; Kalatsova K; Kouki E; Haukka J; Putaala J; Linna M; Aro AL; Mustonen P; Hartikainen J; Lehto M
Eur J Clin Invest; 2024 Jan; 54(1):e14107. PubMed ID: 37823410
[TBL] [Abstract][Full Text] [Related]
3. Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M
Br J Clin Pharmacol; 2023 Jan; 89(1):351-360. PubMed ID: 35986926
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
5. Aortic Stenosis and Outcomes in Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Teppo K; Airaksinen KEJ; Biancari F; Jaakkola J; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Hartikainen J; Aro AL; Lehto M
J Am Heart Assoc; 2023 May; 12(9):e029337. PubMed ID: 37119067
[TBL] [Abstract][Full Text] [Related]
6. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study.
Jaakkola J; Teppo K; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Aro AL; Hartikainen J; Airaksinen KEJ; Lehto M
Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):269-276. PubMed ID: 34677571
[TBL] [Abstract][Full Text] [Related]
7. Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
Ajabnoor AM; Zghebi SS; Parisi R; Ashcroft DM; Rutter MK; Doran T; Carr MJ; Mamas MA; Kontopantelis E
PLoS Med; 2022 Jun; 19(6):e1004003. PubMed ID: 35671329
[TBL] [Abstract][Full Text] [Related]
8. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
Højen AA; Nielsen PB; Riahi S; Jensen M; Lip GYH; Larsen TB; Søgaard M
Br J Clin Pharmacol; 2022 Aug; 88(8):3847-3855. PubMed ID: 35355307
[TBL] [Abstract][Full Text] [Related]
9. Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
Teppo K; Jaakkola J; Langén VL; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Hartikainen J; Airaksinen KEJ; Lehto M
PLoS One; 2022; 17(10):e0276612. PubMed ID: 36315505
[TBL] [Abstract][Full Text] [Related]
10. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
[TBL] [Abstract][Full Text] [Related]
11. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
[TBL] [Abstract][Full Text] [Related]
12. Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database.
Munir MB; Hlavacek P; Keshishian A; Guo JD; Mallampati R; Ferri M; Russ C; Emir B; Cato M; Yuce H; Hsu JC
J Interv Card Electrophysiol; 2023 Apr; 66(3):771-782. PubMed ID: 35804258
[TBL] [Abstract][Full Text] [Related]
13. Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
Bayer V; Kotalczyk A; Kea B; Teutsch C; Larsen P; Button D; Huisman MV; Lip GYH; Olshansky B
J Am Heart Assoc; 2022 Mar; 11(6):e023907. PubMed ID: 35243870
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
[TBL] [Abstract][Full Text] [Related]
15. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation.
Perreault S; de Denus S; White-Guay B; Côté R; Schnitzer ME; Dubé MP; Dorais M; Tardif JC
Pharmacotherapy; 2020 Jan; 40(1):40-54. PubMed ID: 31758592
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
Hatori Y; Sakai H; Hatori N; Kunishima T; Namiki A; Shimizu M; Toyosaki N; Kuwajima M; Sato N;
J Cardiol; 2023 Apr; 81(4):385-389. PubMed ID: 36109256
[TBL] [Abstract][Full Text] [Related]
17. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020.
Ko D; Lin KJ; Bessette LG; Lee SB; Walkey AJ; Cheng S; Kim E; Glynn RJ; Kim DH
JAMA Netw Open; 2022 Nov; 5(11):e2242964. PubMed ID: 36399339
[TBL] [Abstract][Full Text] [Related]
18. Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Tiili P; Lehtonen O; Niemi M; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M
Pharmacol Res Perspect; 2022 Jun; 10(3):e00961. PubMed ID: 35599338
[TBL] [Abstract][Full Text] [Related]
19. Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study.
Halvorsen S; Smith JA; Söderdahl F; Thuresson M; Solli O; Ulvestad M; Jonasson C
BMC Prim Care; 2022 Aug; 23(1):214. PubMed ID: 36008778
[TBL] [Abstract][Full Text] [Related]
20. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Harrington J; Carnicelli AP; Hua K; Wallentin L; Patel MR; Hohnloser SH; Giugliano RP; Fox KAA; Hijazi Z; Lopes RD; Pokorney SD; Hong H; Granger CB
Circulation; 2023 Jun; 147(23):1748-1757. PubMed ID: 37042255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
